These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area. Kim AR; Lee YK; Kim KA; Chu YK; Baik BY; Kim ES; Yun SC; Kim KS; Pi SY J Korean Med Sci; 2006 Feb; 21(1):5-10. PubMed ID: 16479056 [TBL] [Abstract][Full Text] [Related]
26. Indications for the use of cytomegalovirus-seronegative blood products. Preiksaitis JK Transfus Med Rev; 1991 Jan; 5(1):1-17. PubMed ID: 1666324 [No Abstract] [Full Text] [Related]
28. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation. Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289 [TBL] [Abstract][Full Text] [Related]
29. Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients. von Bueltzingsloewen A; Bordigoni P; Witz F; Bene MC; Schmitt C; Lacour B; Sommelet D Bone Marrow Transplant; 1993 Sep; 12(3):197-202. PubMed ID: 8241976 [TBL] [Abstract][Full Text] [Related]
30. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients. Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974 [TBL] [Abstract][Full Text] [Related]
31. [Prevention of post-transfusion cytomegalovirus infection: recommendations for clinical practice]. Zwicky C; Tissot JD; Mazouni ZT; Schneider P; Burnand B Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1061-6. PubMed ID: 10464908 [TBL] [Abstract][Full Text] [Related]
32. Definitions of cytomegalovirus infection and disease in transplant recipients. Ljungman P; Griffiths P; Paya C Clin Infect Dis; 2002 Apr; 34(8):1094-7. PubMed ID: 11914998 [TBL] [Abstract][Full Text] [Related]
33. The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients. Ziemann M; Juhl D; Görg S; Hennig H Transfusion; 2013 Oct; 53(10):2183-9. PubMed ID: 23581526 [TBL] [Abstract][Full Text] [Related]
34. Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program. Rossini F; Terruzzi E; Cammarota S; Morini F; Fumagalli M; Verga L; Elli E; Verga M; Miccolis I; Parma M; Pogliani EM Transpl Infect Dis; 2005; 7(3-4):122-5. PubMed ID: 16390400 [TBL] [Abstract][Full Text] [Related]
35. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood. Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407 [TBL] [Abstract][Full Text] [Related]
36. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study. Narvios AB; Lichtiger B Haematologica; 2001 Jul; 86(7):749-52. PubMed ID: 11454531 [TBL] [Abstract][Full Text] [Related]
37. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients. Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359 [TBL] [Abstract][Full Text] [Related]
38. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK Transfus Med Rev; 2006 Jan; 20(1):45-56. PubMed ID: 16373187 [TBL] [Abstract][Full Text] [Related]
39. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections. Ziemann M; Heuft HG; Frank K; Kraas S; Görg S; Hennig H Transfusion; 2013 May; 53(5):1088-94. PubMed ID: 23320406 [TBL] [Abstract][Full Text] [Related]
40. Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland. Voruz S; Gowland P; Eyer C; Widmer N; Abonnenc M; Prudent M; Masouridi-Levrat S; Duchosal MA; Niederhauser C Blood Transfus; 2020 Nov; 18(6):446-453. PubMed ID: 32203012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]